3.0.0 3709 2023-01-11T13:23:37Z 2023-01-11T13:23:37Z House H HR 2013-12-11 113 From the Congressional Record Online through the Government Publishing Office [www.gpo.gov]By Mr. RUSH:H.R. 3709.Congress has the power to enact this legislation pursuantto the following:Article I, Section 8, Clause 3: ``To regulate commerce . .. among the several states . . .''Article I, Section 8, Clause 8: ``To promote the progressof science . . . by securing for limited times to authors andinventors the exclusive right to their respective writingsand discoveries.''Article I, Section 8, Clause 18: ``To make all laws whichshall be necessary and proper. . .''[Page H7688]]]> hsju00 Judiciary Committee House Standing hsju03 Courts, Intellectual Property, and the Internet Subcommittee Referred to 2014-01-27T22:08:50Z hsju05 Administrative State, Regulatory Reform, and Antitrust Subcommittee Referred to 2014-01-27T22:08:40Z Referred to 2013-12-11T15:02:45Z hsif00 Energy and Commerce Committee House Standing hsif14 Health Subcommittee Referred to 2013-12-13T16:33:58Z Referred to 2013-12-11T15:02:40Z 2014-01-27 hsju03 Courts, Intellectual Property, and the Internet Subcommittee 1 House committee actions Referred to the Subcommittee on Courts, Intellectual Property, and the Internet. Committee 2014-01-27 hsju05 Administrative State, Regulatory Reform, and Antitrust Subcommittee 1 House committee actions Referred to the Subcommittee on Regulatory Reform, Commercial And Antitrust Law. Committee 2013-12-13 hsif14 Health Subcommittee 1 House committee actions Referred to the Subcommittee on Health. Committee 2013-12-11 Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. IntroReferral H11100 2 House floor actions hsju00 Judiciary Committee 2013-12-11 Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. IntroReferral H11100 2 House floor actions hsif00 Energy and Commerce Committee 2013-12-11 Introduced in House IntroReferral Intro-H 9 Library of Congress 2013-12-11 Introduced in House IntroReferral 1000 9 Library of Congress R000515 Rep. Rush, Bobby L. [D-IL-1] BOBBY RUSH D IL L. 1 N V000128 Rep. Van Hollen, Chris [D-MD-8] Chris Van Hollen D MD 8 2013-12-11 True W000215 Rep. Waxman, Henry A. [D-CA-33] HENRY WAXMAN D CA A. 33 2013-12-11 True S001145 Rep. Schakowsky, Janice D. [D-IL-9] JANICE SCHAKOWSKY D IL D. 9 2013-12-12 False H001068 Rep. Huffman, Jared [D-CA-2] Jared Huffman D CA 2 2014-05-21 False S001170 Rep. Shea-Porter, Carol [D-NH-1] Carol Shea-Porter D NH 1 2014-07-14 False Commerce Administrative law and regulatory procedures Competition and antitrust Contracts and agency Federal Trade Commission (FTC) Intellectual property Marketing and advertising Prescription drugs Commerce 00 2013-12-11 Introduced in House 2014-01-16T21:56:53Z Protecting Consumer Access to Generic Drugs Act of 2013 - Prohibits, as an unfair and deceptive act or practice and an unfair method of competition in or affecting interstate commerce, any person from being a party to any agreement resolving or settling a patent infringement claim in which: (1) an abbreviated new drug (generic) application filer receives anything of value; and (2) such filer agrees not to research, develop, manufacture, market or sell the generic drug. Excludes a resolution or settlement that includes no more than: (1) the right to market the generic drug before the expiration of the patent or other exclusivity period, or (2) the waiver of a patent infringement claim for damages.

Authorizes the Federal Trade Commission (FTC) to exempt agreements in furtherance of market competition and for the benefit of consumers.

Amends the Federal Food, Drug, and Cosmetic Act to deem an applicant to have forfeited market exclusivity if the applicant enters into an agreement that violates this Act.

Amends the Medicare Prescription Drug, Improvement, and Modernization Act of 2003 to revise reporting requirements related to agreements between a generic drug applicant and a brand name drug company to include: (1) a description of the subject matter of other agreements between the parties; and (2) a certification that the materials filed represent the complete, final, and exclusive agreement between the parties.

]]> Protecting Consumer Access to Generic Drugs Act of 2013 Display Title Protecting Consumer Access to Generic Drugs Act of 2013 Official Title as Introduced To prohibit brand name drug companies from compensating generic drug companies to delay the entry of a generic drug into the market, and for other purposes. Introduced in House IH Short Titles as Introduced Protecting Consumer Access to Generic Drugs Act of 2013 Introduced in House 2013-12-11T05:00:00Z https://www.govinfo.gov/content/pkg/BILLS-113hr3709ih/xml/BILLS-113hr3709ih.xml 2014-01-27 Referred to the Subcommittee on Courts, Intellectual Property, and the Internet. text/xml EN Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain. Congressional Research Service, Library of Congress This file contains bill summaries and statuses for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.